Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Arizona Drug Profile (revised 3/27/2015) > Indications and Field Use > Flashcards

Indications and Field Use Flashcards

1
Q

ABIXIMAB

indications and field use

A
  • Infusion monitoring during interfacility transport only.
  • Adjunctive to or in preparation of percutaneous transluminal coronary angioplasty
    (PTCA) for the prevention and treatment of acute coronary syndrome and associated acute cardiac ischemic complications in patients at risk for abrupt closure of the treated coronary vessel.
  • Heparin should be concurrently administered and monitored.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ACETYLSALICYLIC ACID, ASPIRIN, ASA

indications and field use

A
  • Chest pain or other signs/symptoms suggestive of acute myocardial infarction
  • ECG changes suggestive of acute myocardial infarction
  • Unstable angina
  • Pain, discomfort, fever in adult patient only
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACETYLSALICYLIC ACID, ASPIRIN, ASA (EMT Administration)

indications and field use

A

Chest pain or other signs/symptoms suggestive of acute myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ADENOSINE

indications and field use

A
  • Conversion of supraventricular tachycardias with no known atrial fibrillation or atrial flutter.
  • Undifferentiated regular monomorphic wide-complex tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALBUMIN, normal serum 5% / 25%

indications and field use

A
  • Restores plasma volume in burns
  • Hyperbilirubinemia
  • Shock
  • Hypoproteinemia
  • Prevention of cerebral edema
  • Cardiopulmonary bypass procedures
  • ARDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ALUTEROL SULFATE

indications and field use

A
  • Treatment of bronchospasm

- Treatment of hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AMIODARONE

indications and field use

A
  • Treatment of: defibrillation-refractory VF/pulseless VT, polymorphic VT, and wide complex tachycardia of uncertain origin.
  • Control hemodynamically stable ventricular tachycardia when cardioversion unsuccessful.
  • Adjunct to cardioversion of SVT and PSVT. Rate control in atrial fibrillation or flutter.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ATROPINE SULFATE

indications and field use

A
  • Symptomatic bradycardia (sinus, junctional, and AV blocks causing significant hypotension, ventricular ectopy, chest pain, altered level of consciousness, etc.), monitored patient only.
  • Acetylcholinesterase inhibitor poisoning (organophosphate, carbamate cholinergic poisoning).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BUMETANIDE

indications and field use

A

Pulmonary edema

Congestive heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CALCIUM CHLORIDE

indications and field use

A
  • Acute hypocalcemia
  • Calcium channel blocker OD
  • Acute hyperkalemia (known or suspected)
  • Hypermagnesemia (Magnesium OD)
  • Pre-treatment for IV calcium channel blocker administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CALCIUM GLUCONATE GEL, 2.5%

indications and field use

A

Used after contact with hydrofluoric acid to mitigate or prevent the related pain and potential tissue burns and bone damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CHARCOAL, ACTIVATED (without sorbitol)

indications and field use

A
  • Sole prehospital therapy of oral ingestion of toxic substances
  • Pre-lavage of oral ingestions of toxic substances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CIMETIDINE

indications and field use

A
  • Infusion monitoring during interfacility transport only
  • Short-term treatment of duodenal ulcer; maintenance therapy
  • Pathological hypersecretory conditions
  • Prevention of upper GI bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DEXAMETHASONE SODIUM PHOSPHATE

indications and field use

A

Reactive airway disease:
Acute exacerbation of bronchial asthma
Anaphylaxis
Cerebral edema (non-traumatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DEXTROSE 50%

indications and field use

A
  • Known hypoglycemia
  • Altered level of consciousness of unknown etiology
  • Seizures of unknown etiology
  • Hyperkalemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DIAZEPAM

indications and field use

A

Grand mal seizures, especially status epilepticus.
Transient analgesia/amnesia for medical procedures (e.g., fracture reduction, cardioversion, pacing).
Delirium tremens.
Treat the cause first.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DILTIAZEM

indications and field use

A

Rapid ventricular rates associated with atrial fibrillation and atrial flutter, and for PSVT refractory to adenosine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

DIPHENHYDRAMINE HCL

indications and field use

A
  • Anaphylaxis (2nd line)
  • Phenothiazine reactions (extrapyramidal symptoms)
  • Antiemetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DOPAMINE

indications and field use

A

Symptomatic bradycardias.
Hemodynamically significant hypotension in the absence of hypovolemia (Cardiogenic or septic shock only after fluid administration; assess breath sounds first).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

EPINEPHRINE AUTO-INJECTOR

indications and field use

A

Indicated in the emergency treatment of anaphylaxis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

EPINEPHRINE HCL

indications and field use

A
  • Cardiac arrest - VF/Pulseless VT; asystole; PEA (First line pharmacologic agent for any pulseless dysrhythmia in cardiopulmonary arrest).
  • Severe bronchospasm, i.e., bronchiolitis, asthma.
  • Anaphylaxis.
  • Bradycardia, refractory with profound hypotension, monitored patient only.
  • Hypotension unresponsive to other therapy, monitored patient only.
  • Croup
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

EPTIFIBATIDE

indications and field use

A
  • Infusion monitoring during interfacility transport only.
  • For the treatment of acute coronary syndrome, for patients to be managed medically or
    those undergoing percutaneous transluminal coronary angioplasty (PTCA) or
    atherectomy.
  • Heparin should be concurrently administered and monitored.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ETOMIDATE

indications and field use

A

Induction of anesthesia for rapid sequence intubation (RSI)

24
Q

FAMOTIDINE

indications and field use

A
  • Infusion monitoring during interfacility transport only.
  • Hospitalized patients who cannot take oral drug or who have intractable ulceration or
    hypersecretory conditions.
25
Q

FENTANYL CITRATE

indications and field use

A
  • Analgesia, especially in patients with burns or other trauma, myocardial infarction, renal colic.
  • Adjunct to sedation in post-intubation state.
  • Adjunct to induction in Rapid Sequence Intubation (RSI) or medication assisted
    intubation.
26
Q

FUROSEMIDE

indications and field use

A

Pulmonary edema; congestive heart failure

27
Q

GLUCAGON

indications and field use

A

Symptomatic hypoglycemia when IV access is delayed.

Beta blocker poisoning

28
Q

HEMOSTATIC AGENTS

indications and field use

A

Life-threatening hemorrhage on external wounds as an adjunct with direct pressure when direct pressure is ineffective.

29
Q

HYDROXOCOBALAMIN

indications and field use

A

Acute, life-threatening known or suspected cyanide poisoning. Symptoms include altered mental status or shock.
Sources of cyanide poisoning include, but are not limited to:
- Smoke inhalation in the setting of a closed space fire.
- Ingestion of cyanide salts
- Industrial accidents, such as mining
- Other cyanide exposures

30
Q

INSULIN

indications and field use

A

Type 1 (insulin-dependent) diabetes mellitus; type 2 (non-insulin-dependent) diabetes mellitus unresponsive to diet and oral hypoglycemics

31
Q

IPRATROPIUM BROMIDE

indications and field use

A

Treatment of bronchospasm associated with chronic obstructive pulmonary disease (emphysema and chronic bronchitis). To be used either alone or in combination with other bronchodilators especially beta adrenergics (i.e., albuterol).

32
Q

KETAMINE HYDROCHLORIC INJECTION

indications and field use

A
  • For 15 years and older
  • Pre-anesthetic (Induction agent) for Rapid Sequence Intubation.
  • Pre-anesthetic for critical asthma patients needing aggressive bronchodilation and
    possible intubation.
33
Q

LIDOCAINE HCL

indications and field use

A
  • Suppression of ventricular arrhythmias (ventricular tachycardia, ventricular fibrillation, PVC’s).
  • Prophylaxis against recurrence after conversion from ventricular tachycardia or ventricular fibrillation.
  • Pain management after IO insertion in conscious patients.
34
Q

LORAZEPAM

indications and field use

A

Status epilepticus
Seizure
Agitation/excited delirium

35
Q

MAGNESIUM SULFATE

indications and field use

A
  • Torsade de pointes, drug of choice
  • Hypomagnesemia
  • Pre-term labor (PTL)
  • Pregnancy-induced hypertension (PIH, toxemia of pregnancy, pre-eclampsia and/or
    eclampsia).
  • Hyperreactive Airway - Severe Asthma
36
Q

METHYLPREDNISOLONE SODIUM SUCCINATE

indications and field use

A

Reactive airway disease: Acute exacerbation of emphysema, chronic bronchitis, asthma Anaphylaxis
Burns potentially involving the airway

37
Q

MIDAZOLAM HYDROCHLORIDE

indications and field use

A
  • Anti-convulsant
  • Sedation
  • Management of acute agitation/excited delirium (treat cause as well, if possible)
  • Induction for intubation
38
Q

MORPHINE SULFATE

indications and field use

A
  • Analgesia
  • Pulmonary edema (cardiogenic).
39
Q

NALMEFENE HCL

indications and field use

A

Antidote for: Opioid poisoning when naloxone is not available May differentiate opioid-induced coma from other causes

40
Q

NALOXONE HCL

indications and field use

A

Antidote for: Opioid poisoning
May differentiate opioid-induced coma from other causes

41
Q

NITROGLYCERIN

indications and field use

A
  • Angina
  • Myocardial infarction
  • Congestive heart failure with pulmonary edema
42
Q

NOREPINEPHRINE

indications and field use

A

Severe hypotension- due to cardiogenic, septic, or neurogenic shock either refractory to intravascular fluid boluses or in which intravascular fluid bolusing is contraindicated (e.g. pulmonary edema).

43
Q

ONDANSETRON

indications and field use

A

Nausea and vomiting

44
Q

OXYTOCIN

indications and field use

A

Postpartum hemorrhage due to uterine atony

45
Q

PHENYLEPHRINE NASAL SPRAY 0.5%

indications and field use

A

Facilitation of nasotracheal intubation

46
Q

PROPARACAINE HYDROCHLORIDE OPTHALMIC

indications and field use

A

Induction of topical anesthesia prior to irrigation of eyes with or without adjuncts e.g. Morgan’s lens.

47
Q

PROPOFOL

indications and field use

A

Intensive care unit (ICU) sedation of intubated mechanically ventilated adult patients

48
Q

RACEMIC EPINEPHRINE

indications and field use

A
  • Croup
  • Chronic Obstructive Lung Disease, Chronic Bronchitis, Bronchiolitis, Bronchial Asthma,
    and other peripheral airway disease
49
Q

RANITIDINE

indications and field use

A
  • Infusion monitoring during interfacility transport only
  • Short-term treatment of duodenal ulcer; maintenance therapy
  • Pathological hypersecretory conditions
50
Q

SODIUM BICARBONATE 8.4%

indications and field use

A
  • Pre-existing metabolic acidosis
  • Poisoning of aspirin, cyclic antidepressants (alkalinization of blood)
  • Cardiac arrest after other interventions and ventilation is adequate
51
Q

SUCCINYLCHOLINE

indications and field use

A

Endotracheal intubation requiring paralysis (RSI) by a qualified Paramedic with authorization from the Paramedic’s administrative medical director

52
Q 
THIAMINE HCL (VITAMIN B1)
indications and field use
A
  • Alcoholism, delirium tremens
  • Coma of unknown origin, especially if alcohol or malnourishment may be involved.
  • Suspect Wernicke or Korsakoff Syndrome
  • Other thiamine deficiency syndromes
  • Severe congestive heart failure
53
Q

TIROFIBAN

indications and field use

A
  • Infusion monitoring during interfacility transport only.
  • For the treatment of acute coronary syndrome, for patients to be managed medically or
    those undergoing percutaneous transluminal coronary angioplasty (PTCA) or
    atherectomy.
  • Heparin should be concurrently administered and monitored.
54
Q

TOTAL PARENTERAL NUTRUITION

indications and field use

A

Indications:
Patients with long-term needs for intravenous feeding, who cannot receive nutrients adequate enough to meet physiologic needs through the gastrointestinal system, including hypercatabolic states (burns, trauma, sepsis, etc.), various gastrointestinal diseases, renal failure, pancreatitis, etc.
Field use:
Inter-facility transport only.

55
Q

VASOPRESSIN

indications and field use

A

Adult shock-refractory ventricular fibrillation/pulseless ventricular tachycardia

56
Q

VERAPAMIL HCL

indications and field use

A
  • Supraventricular tachycardia
  • Atrial fibrillation and atrial flutter with rapid ventricular response

Arizona Drug Profile (revised 3/27/2015) (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions